Dolores Cooper Shockley
Dolores Cooper Shockley (1929-2021) was an American pharmacologist and the first African American woman to earn a Ph.D. in pharmacology. She made significant contributions to the field of neuropharmacology, particularly in the study of drug addiction and neurotransmitters.
Early Life and Education[edit | edit source]
Dolores Cooper Shockley was born on September 24, 1929, in Nashville, Tennessee. She developed an interest in science at a young age, which was nurtured by her parents and teachers. She attended Tennessee State University, where she earned a Bachelor of Science degree in chemistry in 1949.
Shockley then pursued her graduate studies at Purdue University, where she earned a Master's degree in pharmacology in 1951. She continued her studies at Purdue, earning a Ph.D. in pharmacology in 1955, making her the first African American woman to earn a Ph.D. in this field.
Career[edit | edit source]
After earning her Ph.D., Shockley worked as a postdoctoral fellow at the Julius Axelrod Laboratory at the National Institutes of Health. She then joined the faculty of Meharry Medical College in Nashville, where she served as a professor of pharmacology and later as the chair of the department.
Shockley's research focused on the effects of drugs on the central nervous system, particularly in relation to drug addiction. She made significant contributions to the understanding of how drugs affect neurotransmitter release and uptake in the brain.
Legacy[edit | edit source]
Shockley's pioneering work in pharmacology and her role as a trailblazer for African American women in science have been widely recognized. She received numerous awards and honors for her contributions to the field, including the Society for Neuroscience's Mika Salpeter Lifetime Achievement Award.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
- Dolores Cooper Shockley: An Unstoppable Force in Pharmacology (National Center for Biotechnology Information)
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
